24
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T11541 |
HCV-IN-30
|
Others; HCV Protease | Microbiology/Virology; Others; Proteases/Proteasome |
HCV-IN-30 是 HCV NS5A 复制复合物的抑制剂(基因型 1a 和 1b 复制子的 IC50 = 901 和 102 nM)。 | |||
T6229 |
Daclatasvir
Daklinza,达卡他韦,EBP 883,达拉他韦,BMS-790052 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Daclatasvir (EBP 883) 是一种高度选择性的 HCV NS5A 抑制剂,EC50 为 9-50 pM,适用于细胞培养中的多种 HCV 复制子基因型和 JFH-1 基因型 2a 感染性病毒。 | |||
T1786 |
Daclatasvir dihydrochloride
BMS-790052 dihydrochloride,盐酸达拉他韦 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Daclatasvir dihydrochloride (BMS-790052 dihydrochloride) 是有机阴离子转运多肽 1B(OATP1B) 和 OATP1B3抑制剂,IC50分别为 1.5 µM 和 3.27 µM。它也具有口服活性的 HCV NS5A 蛋白抑制剂,多种 HCV 复制子基因型的 EC50范围为 9-146 pM。 | |||
T10493 |
Beclabuvir
BMS-791325 |
Others | Others |
Beclabuvir is an allosteric inhibitor that binds to thumb site 1 of the HCV NS5B RNA-dependent RNA polymerase. It inhibits recombinant NS5B proteins from HCV genotypes 1, 3, 4, and 5 (IC50 < 28 nM). | |||
T5127 |
ABT530
ABT 530,ABT-530,哌仑他韦,Pibrentasvir |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
ABT530 (Pibrentasvir) 是一种 HCV NS5A 抑制剂,针对含有 NS5A 基因型 1-6 的 HCV 复制子,EC50 范围为 1.4-5.0 pM。 | |||
T4547 |
Grazoprevir
MK-5172 |
HCV Protease; SARS-CoV | Microbiology/Virology; Proteases/Proteasome |
Grazoprevir (MK-5172) 是一种丙型肝炎病毒 NS3/4a 蛋白酶的选择性抑制剂,具有跨基因型和耐药变体的广泛活性,对 gt1b、gt1a、gt2a、gt2b 和 gt3a 的Ki 分别为 0.01 nM、0.01 nM、0.08 nM、0.15 nM 和 0.90 nM。它也是 SARS-CoV-2 3CLpro 抑制剂。 | |||
T7158 |
Ombitasvir
奥比他韦,ABT-267 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Ombitasvir (ABT-267) 是丙型肝炎病毒非结构蛋白 5A 的口服生物可利用的强效抑制剂。对 HCV 基因型 1 至 5 的 EC50 为 0.82 至 19.3 pM,对基因型 6a 的 EC50 为 366 pM。 | |||
T3334 |
Velpatasvir
GS-5816,维帕他韦 |
HCV Protease; SARS-CoV | Microbiology/Virology; Proteases/Proteasome |
Velpatasvir (GS-5816) 是一种的 HCV NS5A 抑制剂。它也是 SARS-CoV 3CLpro 的抑制剂,IC50为 2.16 μM。 | |||
T71006 |
BI-1388
|
||
BI-1388 is a highly potent inhibitor of HCV NS3 protease activity, inhibiting viral replication for various HCV genotypes and for resistant mutants D168V and R155K. | |||
T68235 |
Beclabuvir HCl
|
||
Beclabuvir, also known as BMS-791325, is an allosteric inhibitor that binds to thumb site 1 of the hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase. BMS-791325 inhibits recombinant NS5B proteins from HCV genotypes 1, 3, 4, and 5 at 50% inhibitory concentrations (IC50) below 28 nM. In cell culture, BMS-791325 inhibited replication of HCV subgenomic replicons representing genotypes 1a and 1b at 50% effective concentrations (EC50s) of 3 nM and 6 nM, respectively, with similar (3 to 18 nM) ... | |||
T63090 | SMCypI C31 | ||
SMCypIC31 是一种非肽类 cyclophilin 抑制剂,能够有效抑制肽基-脯氨酰顺/反异构酶 (PPIase) (IC50: 0.1 μM)。SMCypI C31 可以破坏亲环蛋白 A-NS5A 相互作用。SMCypI C31 具有泛基因型抗 HCV 效果,对基因型 1a,1b,2a,3a 和 5a HCV-SGRs 和嵌合基因型 2a/4a HCV-SGRs 的 EC50 范围为 1.20-7.76 μM。 | |||
T12065 |
Grazoprevir sodium salt
MK-5172 (sodium salt) |
Others | Others |
Grazoprevir sodium salt is a selective Hepatitis C virus NS3/4a protease inhibitor with broad activity across genotypes and resistant variants. | |||
T13852 | PSI-7409 tetrasodium | Others | Others |
PSI-7409 tetrasodium is an active 5'-triphosphate metabolite of sofosbuvir (PSI-7977)(IC50s of 1.6, 2.8, 0.7 and 2.6 μM for GT 1b_Con1, GT 2a_JFH1, GT 3a, and GT 4a NS5B polymerases, respectively). | |||
T27485 |
GSK-625433
|
||
GSK-625433, a homochiral inhibitor of the hepatitis C virus (HCV) RNA-dependent RNA polymerase, has the ability to inhibit the polymerase of both HCV genotypes 1a and 1b. | |||
T27461 |
GSK2336805
GSK 2336805,GSK-2336805,JNJ-56914845,GSK-805,GSK805 |
||
GSK-2336805 is a HCV NS5A inhibitor. GSK2336805 retained activity on chimeric replicons containing NS5A patient sequences from genotype 1 and patient and consensus sequences for genotypes 4 and 5 and part of genotype 6. | |||
TP1468 |
HCV-IN-4
|
||
HCV-IN-4, a potent and orally active inhibitor of HCV NS5A, demonstrates significant efficacy against genotypes GT1a, GT2b, GT3a, and the GT1a mutations Y93H and L31V. Its half-maximal effective concentrations (EC90s) are 3 pM, 0.3 nM, 0.01 nM, 0.5 nM, and 0.02 nM, respectively[1]. | |||
T19627 |
Ciluprevir
BILN 2061ZW,BILN 2061,BILN-2061ZW,BILN-2061,BILN2061ZW,BILN2061 |
||
Ciluprevir is an effective and selective HCV NS3 protease inhibitor with proven antiviral effect in humans. Ciluprevir may be an antiviral agent for individuals infected with non-genotype-1 HCV. In vitro sensitivity studies with Ciluprevir showed a decrea | |||
T74495 | NS5A-IN-4 | ||
NS5A-IN-4 (Compound 1.12) 是一种具有口服活性的泛基因型丙型肝炎病毒 (HCV)NS5A 抑制剂,对gT1b、gT1a、gT2a、gT3a,gT4a 和gT5a 的IC50分别为 1.2、2296、4.6、362、10.3 和 693 pM。 | |||
T37923 |
7(Z)-Pentacosene
|
||
7(Z)-Pentacosene is an unsaturated cuticular hydrocarbon that acts as a contact sex pheromone in fruit flies. In different species and genotypes of Drosophila, it can be found on both males and females. Pentacosene may stimulate copulation either by itself at high concentrations or when combined with other alkenes. Interestingly, the absolute level of pentacosene increases in Drosophila females immediately after copulation. | |||
T74625 |
HCV-IN-41
|
||
HCV-IN-41 (compound 4) 是一种高效的丙肝病毒 (HCV)抑制剂,对 HCV1b、2a、3a 和 4a 的 EC50分别为 0.006762 nM、5.183 nM、1.365 nM 和 142.2 nM。HCV-IN-41 能降低 HCVRNA 的复制。 | |||
T76523 |
HCV Core Protein (107-114)
|
||
HCVCore Protein (107-114) 是主要线性 HCV 核心区域中免疫原性极低的残基。HCVCore Protein (107-114) 被鉴定为 101-118 区域内的结合位点,其包含基因型 Ⅰ/Ⅱ 和基因型 Ⅲ/Ⅵ 之间不同的两个残基。HCVCore Protein (107-114) 可能是传播 HCV 血清型的潜在位点。 | |||
T23407 | surface antigen (208-215) [Hepatitis B Virus] | Others | Others |
The nucleocapsid of the hepatitis B virus is covered by an envelope of HBV surface antigen (HBsAg), which has the common, group-specific determinant a. The four major subtypes of HBsAg, adw, adr, ayw and ayr, are generated, and they have been proposed to | |||
T73898 |
Paritaprevir dihydrate
|
||
Paritaprevir (ABT-450) dihydrate,一种口服非结构蛋白3/4A (NS3/4A) 蛋白酶抑制剂,对HCV1a 和 1b 具有高效抗病毒活性,EC50值分别为1 nM 和 0.21 nM。此外,其作为SARS-CoV3CLpro 抑制剂,IC50为1.31 μM。其主要通过细胞色素P450 (CYP) 3A代谢,且利托那韦 (Ritonavir,CYP450 抑制剂) 能增强其血浆浓度和延长半衰期。 | |||
T38131 | (E)-10-Hydroxynortriptyline | ||
(E)-10-Hydroxynortriptyline (E-10-OH-NT) is a metabolite of Nortriptyline . Nortriptyline is a tricyclic antidepressant and the main active metabolite of Amitriptyline, and is used to relieve the symptoms of depression[1]. [1]. Shimoda K, et al. The impact of CYP2C19 and CYP2D6 genotypes on metabolism of amitriptyline in Japanese psychiatric patients. J Clin Psychopharmacol. 2002 Aug;22(4):371-8. [2]. Shimoda K, et al. Dean L. Amitriptyline Therapy and CYP2D6 and CYP2C19 Genotype. Biotechnology ... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN3809 | Dehydrojuncusol | HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Dehydrojuncusol, a new inhibitor of hepatitis C virus RNA replication, it inhibits infection of different HCV genotypes by targeting the NS5A protein and is active against resistant HCV variants frequently found in patients with treatment failure. |